Introduction NAC has led to an increase in breast conserving surgery (BCS) worldwide. This
study aims to analyse trends in the use of neoadjuvant chemotherapy (NAC) and the impact …

Purpose The extended role of breast-conserving surgery (BCS) in the neoadjuvant setting
may raise concerns on the oncologic safety of BCS compared to mastectomy. This study …

Background Neoadjuvant chemotherapy (NACT) is increasingly used in patients with
operable disease due to the potential of converting patients requiring mastectomy to breast …

Purpose Neoadjuvant chemotherapy (NACT) is increasingly used in breast cancer
treatment. One of the main goals of NACT is to reduce the extent of local surgery of the …

Background Neoadjuvant chemotherapy (NAC) increases breast‐conserving surgery (BCS)
rates with comparable locoregional control and survival outcomes to adjuvant therapy. More …

Background Neoadjuvant therapy (NAT) for operable breast cancer may facilitate more
breast-conserving surgery (BCS). It seems, however, that this benefit is not being realized …

Simple Summary Neoadjuvant therapy (NAT) has transformed the treatment of advanced
breast cancer (BC), making previously inoperable tumors operable and allowing for the …

Background With limited sample sizes and single-institution designs, how complete
response (CR) after neoadjuvant chemotherapy (NAC) influences breast conserving surgery …

Neo‐adjuvant chemotherapy (NAC) is used to facilitate radical surgery for initially
irresectable or locally advanced breast cancer. The indication for NAC has been extended to …

Introduction Surgical therapy for newly diagnosed breast cancer has changed over the past
decade, but these trends have not been well documented in patients undergoing …